Oral administration of a fraction from Arctium lappa L. enriched in the germacranolide onopordopicrin decreased colitis-associated histological damage in rats and prevented mucin layer loss, which is a common feature of inflammatory bowel diseases (IBD) responsible for a defective barrier function. This evidence concerns the gene MUC5AC and inflammatory bowel disease.